120 related articles for article (PubMed ID: 15694510)
21. Phi (Φ) and psi (Ψ) angles involved in malarial peptide bonds determine sterile protective immunity.
Patarroyo ME; Moreno-Vranich A; Bermúdez A
Biochem Biophys Res Commun; 2012 Dec; 429(1-2):75-80. PubMed ID: 23142598
[TBL] [Abstract][Full Text] [Related]
22. Distorting malaria peptide backbone structure to enable fitting into MHC class II molecules renders modified peptides immunogenic and protective.
Cifuentes G; Patarroyo ME; Urquiza M; Ramirez LE; Reyes C; Rodriguez R
J Med Chem; 2003 May; 46(11):2250-3. PubMed ID: 12747797
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the permissive association of a malaria T cell epitope with DR molecules.
Kilgus J; Jardetzky T; Gorga JC; Trzeciak A; Gillessen D; Sinigaglia F
J Immunol; 1991 Jan; 146(1):307-15. PubMed ID: 1701796
[TBL] [Abstract][Full Text] [Related]
24. Functional, structural, and immunological compartmentalisation of malaria invasive proteins.
Reyes C; Patarroyo ME; Vargas LE; Rodríguez LE; Patarroyo MA
Biochem Biophys Res Commun; 2007 Mar; 354(2):363-71. PubMed ID: 17239816
[TBL] [Abstract][Full Text] [Related]
25. Structural characteristics of immunogenic liver-stage antigens derived from P. falciparum malarial proteins.
Cifuentes G; Vanegas M; Martinez NL; Pirajan C; Patarroyo ME
Biochem Biophys Res Commun; 2009 Jul; 384(4):455-60. PubMed ID: 19422790
[TBL] [Abstract][Full Text] [Related]
26. MSP-1 malaria pseudopeptide analogs: biological and immunological significance and three-dimensional structure.
Lozano JM; Alba MP; Vanegas M; Silva Y; Torres-Castellanos JL; Patarroyo ME
Biol Chem; 2003 Jan; 384(1):71-82. PubMed ID: 12674501
[TBL] [Abstract][Full Text] [Related]
27. 6746 SERA peptide analogues immunogenicity and protective efficacy against malaria is associated with short alpha helix formation: malaria protection associated with peptides alpha helix shortening.
Alba MP; Salazar LM; Puentes A; Pinto M; Torres E; Patarroyo ME
Peptides; 2003 Jul; 24(7):999-1006. PubMed ID: 14499278
[TBL] [Abstract][Full Text] [Related]
28. Based on HLA-DR beta1* allele binding specificities, striking differences in distance and TCR Contacting Residue Orientation can be observed in modified protection-inducing malarial synthetic peptides.
Patarroyo ME; Cifuentes G; Salazar LM; Espejo F; Alba MP; Bermúdez A
Curr Med Chem; 2005; 12(24):2849-65. PubMed ID: 16305475
[TBL] [Abstract][Full Text] [Related]
29. Structural modifications to a high-activity binding peptide located within the PfEMP1 NTS domain induce protection against P. falciparum malaria in Aotus monkeys.
Curtidor H; Torres MH; Alba MP; Patarroyo ME
Biol Chem; 2007 Jan; 388(1):25-36. PubMed ID: 17214546
[TBL] [Abstract][Full Text] [Related]
30. The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity.
Bongfen SE; Ntsama PM; Offner S; Smith T; Felger I; Tanner M; Alonso P; Nebie I; Romero JF; Silvie O; Torgler R; Corradin G
Vaccine; 2009 Jan; 27(2):328-35. PubMed ID: 18984024
[TBL] [Abstract][Full Text] [Related]
31. Atomic evidence that modification of H-bonds established with amino acids critical for host-cell binding induces sterile immunity against malaria.
Patarroyo ME; Cifuentes G; Piraján C; Moreno-Vranich A; Vanegas M
Biochem Biophys Res Commun; 2010 Apr; 394(3):529-35. PubMed ID: 20206601
[TBL] [Abstract][Full Text] [Related]
32. A pre-PEXEL histidine-rich protein II erythrocyte binding peptide as a new way for anti-malarial vaccine development.
Cifuentes G; Patarroyo ME; Reyes C; Córtes J; Patarroyo MA
Biochem Biophys Res Commun; 2007 Aug; 360(1):149-55. PubMed ID: 17588541
[TBL] [Abstract][Full Text] [Related]
33. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
Dobaño C; Doolan DL
Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
[TBL] [Abstract][Full Text] [Related]
34. Comparison of cellular and humoral responses to recombinant protein and synthetic peptides of exon2 region of Plasmodium falciparum erythrocyte membrane protein1 (PfEMP1) among malaria patients from an endemic region.
Das P; Grewal JS; Mahajan B; Chauhan VS
Parasitol Int; 2007 Mar; 56(1):51-9. PubMed ID: 17258500
[TBL] [Abstract][Full Text] [Related]
35. Amino terminal peptides from the Plasmodium falciparum EBA-181/JESEBL protein bind specifically to erythrocytes and inhibit in vitro merozoite invasion.
Vera-Bravo R; Valbuena JJ; Ocampo M; Garcia JE; Rodriguez LE; Puentes A; Lopez R; Curtidor H; Torres E; Trujillo M; Tovar DR; Patarroyo MA; Patarroyo ME
Biochimie; 2005 May; 87(5):425-36. PubMed ID: 15820749
[TBL] [Abstract][Full Text] [Related]
36. Steric-electronic effects in malarial peptides inducing sterile immunity.
Moreno-Vranich A; Patarroyo ME
Biochem Biophys Res Commun; 2012 Jul; 423(4):857-62. PubMed ID: 22713469
[TBL] [Abstract][Full Text] [Related]
37. Protection against malaria induced by chirally modified Plasmodium falciparum's MSP-1 42 pseudopeptides.
Lozano JM; Espejo F; Vera R; Vargas LE; Rosas J; Lesmes L; Torres E; Cortés J; Silva Y; Patarroyo ME
Biochem Biophys Res Commun; 2005 Apr; 329(3):1053-66. PubMed ID: 15752762
[TBL] [Abstract][Full Text] [Related]
38. NMR structure of Plasmodium falciparum malaria peptide correlates with protective immunity.
Purmova J; Salazar LM; Espejo F; Torres MH; Cubillos M; Torres E; Lopez Y; Rodríguez R; Patarroyo ME
Biochim Biophys Acta; 2002 May; 1571(1):27-33. PubMed ID: 12031287
[TBL] [Abstract][Full Text] [Related]
39. Electrostatic potential as a tool to understand interactions between malaria vaccine candidate peptides and MHC II molecules.
Agudelo WA; Galindo JF; Patarroyo ME
Biochem Biophys Res Commun; 2011 Jul; 410(3):410-5. PubMed ID: 21672519
[TBL] [Abstract][Full Text] [Related]
40. Protection against experimental P falciparum malaria is associated with short AMA-1 peptide analogue alpha-helical structures.
Cubillos M; Salazar LM; Torres L; Patarroyo ME
Biochimie; 2002 Dec; 84(12):1181-8. PubMed ID: 12628294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
